Selective Translation of ZNF281 as Part of the Integrated Stress Response System has Therapeutic Relevance for Cardio-Oncology
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 18 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE325898_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1227919 and SRA study SRP566289. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 17 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 17 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9616294 RNA_Control_1 RNA_Control
- GSM9616295 RNA_Control_2 RNA_Control
- GSM9616296 RNA_Control_3 RNA_Control
- GSM9616297 RNA_ZNF281_OE_1 RNA_ZNF281_OE
- GSM9616298 RNA_ZNF281_OE_2 RNA_ZNF281_OE
- GSM9616299 RNA_ZNF281_OE_3 RNA_ZNF281_OE
- GSM9616300 RNA_A549_Parental_1
- GSM9616301 RNA_A549_ZNF281 KO_1 RNA_A549_ZNF281 KO
- GSM9616302 RNA_A549_ZNF281 KO_2 RNA_A549_ZNF281 KO
- GSM9616303 ZNF_ChIP_Control_1 ZNF_ChIP_Control
- GSM9616304 ZNF_ChIP_Control_2 ZNF_ChIP_Control
- GSM9616305 ZNF_ChIP_Control_3 ZNF_ChIP_Control
- GSM9616306 ZNF_ChIP_ZNF281_OE_1 ZNF_ChIP_ZNF281_OE
- GSM9616307 ZNF_ChIP_ZNF281_OE_2 ZNF_ChIP_ZNF281_OE
- GSM9616308 ZNF_ChIP_ZNF281_OE_3 ZNF_ChIP_ZNF281_OE
- GSM9616309 ZNF281_ChIP_Tumor_Parental_1 ZNF281_ChIP_Tumor_Paren…
- GSM9616310 ZNF281_ChIP_Tumor_Parental_2 ZNF281_ChIP_Tumor_Paren…
- GSM9616311 ZNF281_ChIP_Tumor_Parental_3 ZNF281_ChIP_Tumor_Paren…
- GSE261915 Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cells 21 samples shares therapeutic, integrated
- GSE283532 MOZ and HBO1 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia 70 samples shares therapeutic
- GSE298719 A Human Single-cell Atlas Identifies OLR1+ Scar-associated Macrophages as a Therapeutic Target for Chronic Liver Disease 41 samples shares therapeutic
- GSE256101 Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation 53 samples shares translation
- GSE303627 MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia [CUT&Run] 46 samples shares therapeutic
- GSE266956 Increased translation driven by a non-canonical EZH2 cistrome creates a synthetic vulnerability in enzalutamide-resistant prostate cancer 42 samples shares translation
- GSE85390 EZH2 is a potential therapeutic target for H3K27M mutant paediatric gliomas 38 samples shares therapeutic
- GSE209813 DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma 34 samples shares therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.